Vivek Naranbhai

9.5k total citations · 4 hit papers
78 papers, 4.0k citations indexed

About

Vivek Naranbhai is a scholar working on Infectious Diseases, Immunology and Virology. According to data from OpenAlex, Vivek Naranbhai has authored 78 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 30 papers in Immunology and 19 papers in Virology. Recurrent topics in Vivek Naranbhai's work include HIV Research and Treatment (19 papers), Immune Cell Function and Interaction (18 papers) and Tuberculosis Research and Epidemiology (14 papers). Vivek Naranbhai is often cited by papers focused on HIV Research and Treatment (19 papers), Immune Cell Function and Interaction (18 papers) and Tuberculosis Research and Epidemiology (14 papers). Vivek Naranbhai collaborates with scholars based in United States, South Africa and United Kingdom. Vivek Naranbhai's co-authors include Wilfredo F. García-Beltrán, A. John Iafrate, Evan C. Lam, Kerri St. Denis, Alejandro B. Balazs, David J. Gregory, Blake M. Hauser, Mark C. Poznansky, Adam D. Nitido and Jared Feldman and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Vivek Naranbhai

72 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

2021 849 citations Wilfredo F. García-Beltrán, Evan C. Lam et al. profile →
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

2022 651 citations Wilfredo F. García-Beltrán, Kerri St. Denis et al. profile →
Innate Immune Activity Conditions the Effect of Regulatory Variants upon Monocyte Gene Expression

2014 475 citations Vivek Naranbhai et al. profile →
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals

2022 157 citations Vivek Naranbhai, Cristhian Berrios et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vivek Naranbhai United States	28	2.4k	1.1k	918	682	439	78	4.0k
Jennifer A. Juno Australia	25	3.3k 1.4×	1.3k 1.1×	676 0.7×	584 0.9×	285 0.6×	81	4.7k
Georg M. N. Behrens Germany	40	2.7k 1.1×	2.5k 2.2×	935 1.0×	1.0k 1.5×	601 1.4×	166	6.8k
Alejandro B. Balazs United States	29	3.1k 1.3×	1.2k 1.1×	1.6k 1.7×	692 1.0×	322 0.7×	73	5.5k
Jennifer M. Dan United States	20	3.4k 1.4×	1.3k 1.1×	914 1.0×	539 0.8×	248 0.6×	36	4.3k
Alan C. Whitmore United States	28	2.3k 1.0×	1.2k 1.0×	817 0.9×	536 0.8×	263 0.6×	66	4.0k
Alba Grifoni United States	30	5.5k 2.4×	1.9k 1.6×	1.8k 1.9×	585 0.9×	411 0.9×	116	7.0k
Deborah Cromer Australia	25	2.9k 1.2×	624 0.5×	520 0.6×	597 0.9×	170 0.4×	70	4.0k
Jörg Timm Germany	35	1.4k 0.6×	1.2k 1.0×	559 0.6×	1.9k 2.8×	213 0.5×	145	4.7k
Aneesh K. Mehta United States	33	2.0k 0.8×	1.4k 1.2×	652 0.7×	1.7k 2.5×	253 0.6×	90	4.4k
Richard B. Kennedy United States	42	2.0k 0.8×	2.2k 1.9×	1.8k 1.9×	1.9k 2.8×	572 1.3×	166	5.7k

Countries citing papers authored by Vivek Naranbhai

Since Specialization

Citations

This map shows the geographic impact of Vivek Naranbhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Naranbhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Naranbhai more than expected).

Fields of papers citing papers by Vivek Naranbhai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivek Naranbhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Naranbhai. The network helps show where Vivek Naranbhai may publish in the future.

Co-authorship network of co-authors of Vivek Naranbhai

This figure shows the co-authorship network connecting the top 25 collaborators of Vivek Naranbhai. A scholar is included among the top collaborators of Vivek Naranbhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivek Naranbhai. Vivek Naranbhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gorelick, Sergey, et al.. (2025). Mind the corner: Fillets in cryo-FIB lamella preparation to minimise sample loss caused by stress concentration and lamella breakage. Journal of Structural Biology. 217(4). 108249–108249.

Parakh, Sagun, et al.. (2025). Utility of bronchoalveolar lavage in checkpoint inhibitor pneumonitis evaluation: a narrative review. Translational Lung Cancer Research. 14(10). 4628–4637.

Hamilton, Fergus, Haiko Schurz, Tom Yates, et al.. (2024). Altered IL-6 signalling and risk of tuberculosis: a multi-ancestry mendelian randomisation study. The Lancet Microbe. 6(1). 100922–100922. 5 indexed citations

Thierauf, Julia, Stefan T. Kaluziak, Aikaterini Dedeilia, et al.. (2023). Prognostic biomarkers for survival in mucosal melanoma.. Journal of Clinical Oncology. 41(16_suppl). e21576–e21576.

Luo, Weiyu, Chenfeng Xiong, Natalia Blanco, et al.. (2023). Revealing human mobility trends during the SARS-CoV-2 pandemic in Nigeria via a data-driven approach. South African Journal of Science. 119(5/6). 3 indexed citations

Bashirova, Arman, Mathias Viard, Lee Garner, et al.. (2023). HLA class I signal peptide polymorphism determines the level of CD94/NKG2–HLA-E-mediated regulation of effector cell responses. Nature Immunology. 24(7). 1087–1097. 32 indexed citations

Thierauf, Julia, Stefan T. Kaluziak, Soma Jobbagy, et al.. (2023). Prognostic biomarkers for survival in mucosal melanoma. Pigment Cell & Melanoma Research. 36(5). 378–387. 1 indexed citations

Schurz, Haiko, Vivek Naranbhai, Tom Yates, et al.. (2023). Multi-ancestry meta-analysis of host genetic susceptibility to tuberculosis identifies shared genetic architecture. eLife. 13. 12 indexed citations

Le, Thomas K., Isabelle Brown, Rebecca Goldberg, et al.. (2022). Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Pharmacovigilance Study. Journal of Investigative Dermatology. 142(11). 2896–2908.e4. 15 indexed citations

10.

Naranbhai, Vivek, Mathias Viard, Michael Dean, et al.. (2021). HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study. The Lancet Oncology. 23(1). 172–184. 64 indexed citations

11.

Naranbhai, Vivek, Kerri St. Denis, Evan C. Lam, et al.. (2021). Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy. Radiotherapy and Oncology. 166. 88–91. 9 indexed citations

12.

García-Beltrán, Wilfredo F., Kerri St. Denis, Angelique Hœlzemer, et al.. (2021). mRNA-Based COVID-19 Vaccine Boosters Induce Neutralizing Immunity Against SARS-CoV-2 Omicron Variant. SSRN Electronic Journal. 13 indexed citations

13.

Chang, Christina C., Vivek Naranbhai, Michael Roche, et al.. (2018). Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1. AIDS. 32(15). 2119–2128. 25 indexed citations

14.

Körner, Christian, Camille R. Simoneau, Philipp Schommers, et al.. (2017). HIV-1-Mediated Downmodulation of HLA-C Impacts Target Cell Recognition and Antiviral Activity of NK Cells. Cell Host & Microbe. 22(1). 111–119.e4. 30 indexed citations

15.

Reechaipichitkul, Wipa, et al.. (2017). Chemokines additional to IFN-γ can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype. Tuberculosis. 105. 28–34. 21 indexed citations

16.

Kharsany, Ayesha B. M., Zizipho Z. A. Mbulawa, Vivek Naranbhai, et al.. (2016). High Burden of Human Papillomavirus (HPV) Infection among Young Women in KwaZulu-Natal, South Africa. PLoS ONE. 11(1). e0146603–e0146603. 41 indexed citations

17.

Laeyendecker, Oliver, Andrew D. Redd, Martha Nason, et al.. (2015). Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis. The Journal of Infectious Diseases. 212(5). 754–759. 21 indexed citations

18.

Mills, Tara C., Anna Rautanen, Tom Parks, et al.. (2013). IFITM3 and Susceptibility to Respiratory Viral Infections in the Community. The Journal of Infectious Diseases. 209(7). 1028–1031. 63 indexed citations

19.

Valley‐Omar, Ziyaad, Sengeziwe Sibeko, Jeffrey A. Anderson, et al.. (2012). CAPRISA 004 Tenofovir Microbicide Trial: No Impact of Tenofovir Gel on the HIV Transmission Bottleneck. The Journal of Infectious Diseases. 206(1). 35–40. 14 indexed citations

20.

Naranbhai, Vivek, Salim S. Abdool Karim, Marcus Altfeld, et al.. (2012). Innate Immune Activation Enhances HIV Acquisition in Women, Diminishing the Effectiveness of Tenofovir Microbicide Gel. The Journal of Infectious Diseases. 206(7). 993–1001. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact